Top 5 stock gainers and losers: TCF.C, MDNA.TO, DOSE.C

In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets.

Here is a summary of the intraday action of assets:

Top 5 Gainers

Total Helium (TOH.V)

Market Cap ~ $22 million

Total Helium Ltd. operates as a helium exploration, production, and storage solutions company in the United States. It holds 50% interest in the Pinta South project located in the Holbrook Basin of Arizona; and the Helisium Project located in the State of Kansas.

The stock is up 43.3% on no news, however four days ago, the Company announced a management change and special concession.

After printing record lows, the stock is recovering and today’s candle could confirm a close above the current lower high at $0.195. This would be a strong sign that the current downtrend is over.

Horizonte Minerals (HZM.TO)

Market Cap ~ $94 million

Horizonte Minerals Plc, together with its subsidiaries, engages in the exploration and development of mineral projects in Brazil. The company primarily explores for nickel deposits, as well as cobalt deposits. It holds 100% interest in the Araguaia ferronickel; and the Vermelho Nickel-Cobalt project in the eastern part of the Carajás mining district.

The stock is up 27.2% on no news.

A stock which printed all time record lows and is bouncing at the psychological zone of $0.25. Message boards are quiet on this one so no real information on the gap up pop.

Trillion Energy International (TCF.C)

Market Cap ~ $31 million

Trillion Energy International Inc. operates as an oil and gas exploration and production company with assets in Turkey and Bulgaria. It owns 49% interests in the SASB natural gas field covering an area of 12,387 hectares; 19.6% ownership interest in the Cendere oil field; and 50% operating interest in the Bakuk gas field located near the Syrian border.

The stock is up 29% on no news. Four days ago, the Company provided an update on its three well perforation program at the SASB gas field. So far, two out of the three well operations have now been commenced or successfully completed. As a result, total combined production at SASB is currently 14.4 MMcf/d (100%) – 7,056 MMCF/d net to Trillion into the gas sales pipeline.

When you zoom out of the chart, you will see that there is support at the $0.25 zone. This is where the stock is seeing some bids come in as evident by the large wick candle printed on October 30th 2023. The lower high comes in at $0.75 so there is still a lot of work to be done for bulls to take charge.

Medicenna Therapeutics (MDNA.TO)

Market Cap ~ $21 million

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines.

The stock is up 20% on news that new preclinical data demonstrating proof of concept for the Company’s novel T-MASK (Targeted Metallo/protease Activated SuperKine) platform technology with the Company’s development candidate, MDNA113.

The stock is bouncing from printing record lows and now needs to contend with the resistance at $0.36 and the lower high at $0.42.

Theratechnologies (TH.TO)

Market Cap ~ $43 million

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer.

The stock is up 20% on no news. However, three days ago, the Company announced a US $25 million public offering.

The stock did not break below previous lows and instead ranged before bouncing at the $1.25 level. With today’s close, the small gap could also be filled which points to bullish price action.

Top 5 Losers

Rapid Dose Therapeutics (DOSE.C)

Market Cap ~ $13 million

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries.

The stock is down 40% on no news.

The stock did confirm a breakout but this has been nullified with today’s candle. This is definitely a very bearish sign.

First American Uranium (URM.C)

Market Cap ~ $2.3 million

First American Uranium Inc., a junior mining company, engages in the identification, acquisition, and exploration of mineral properties in Canada. It holds an option to acquire a 100% interest in the Red Basin uranium/vanadium project located in Catron County, New Mexico; and the Silver Lake property comprising eight contiguous mineral claims that covers an area of approximately 1,647.24 hectares located to the southeast of the town of Houston, in the Omineca Mining Division.

The stock is down 26.3% on no news.

The stock is breaking down a major support zone here. Next stop? Previous record lows.

Solis Minerals Ltd (SLMN.V)

Market Cap ~ $18 million

Solis Minerals Ltd. acquires, explores for, and develops mineral properties. The company primarily explores for copper, gold, silver, lithium, and iron oxide. It owns a 100% interest in the Ilo Norte and Ilo Este copper properties that covers an area of approximately 10,900 hectares; and the Cinto Copper Project consisting of seven exploration concessions totalling 3,000 hectares located in Southern Peru. The company also holds a 100% interest in the Borborema Lithium Project that covers an area of 25,600 hectares located in Northeastern Brazil.

The stock is down 20% on no news.

The stock has been trending downwards but is now testing a key support area of $0.195. A break here would take us down to fill the gap and close below $0.14.

Akumin (AKU.TO)

Market Cap ~ $38 million

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states.

The stock is down 17.6% on news of an update on trading on the Toronto Stock Exchange. The Toronto Stock Exchange (“TSX”) has advised the Company that trading of its common stock will resume on the opening of markets on November 3, 2023.

The stock is finding buyers at the breakout zone. The range with resistance at $0.28 was taken out and buyers are coming in on the retest. Watch for recent highs to be taken out in the next few days or weeks.

Avanti Helium (AVN.V)

Market Cap ~ $32 million

Avanti Helium Corp. acquires, explores, and develops helium projects in Canada and the United States. The company’s principal project is its 100% owned Greater Knappen Project, which covers an area of approximately 70,140 acres located in the Southern Alberta and Northwestern Montana.

The stock is down 19% on news of pricing of the overnight marketed best efforts public offering of units of the Company. Pursuant to the Offering, which is being conducted on a “best efforts” agency basis, Avanti will issue 6,667,000 Units at a price of $0.45 per Unit for aggregate gross proceeds of up to $3,000,150. Each Warrant will entitle the holder to acquire one Common Share for 24 months from the closing of the Offering at an exercise price of $0.60.